covid
Buscar en
Porto Biomedical Journal
Toda la web
Inicio Porto Biomedical Journal The effects of cannabinoids in exemestane-resistant breast cancer cells
Información de la revista
Vol. 2. Núm. 5.
Páginas 221-222 (septiembre - octubre 2017)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. 5.
Páginas 221-222 (septiembre - octubre 2017)
PS181
Open Access
The effects of cannabinoids in exemestane-resistant breast cancer cells
Visitas
7618
C. Almeida1,2,3,
Autor para correspondencia
cristina-almeida96@hotmail.com

Corresponding author.
, T. Augusto3, G. Correia-da-Silva3,4, N. Teixeira4, C. Amaral4
1 Faculdade de Ciências, Universidade do Porto, Portugal
2 Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Portugal
3 Laboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Portugal
4 UCIBIO, REQUIMTE, Laboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

Aim: Considering that the development of resistance is the main reason for endocrine treatment failure, our group decided to explore the ability of three cannabinoids, Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD) and anandamide (AEA), to reverse resistance to exemestane. The THC and CBD are phytocannabinoids derived from the plant Cannabis sativa (marijuana) whereas AEA is an endocannabinoid. For that, it was used LTEDaro cells, a long-term estrogen deprived ER+ breast cancer cell line that mimics resistance to exemestane.1 These cells were treated with exemestane in combination with two phytocannabinoids, CBD and THC, and the endocannabinoid AEA.

Introduction: Exemestane is one of the aromatase inhibitors (AI) used as first line treatment for estrogen-receptor positive breast cancer in post-menopausal women. Exemestane acts by inhibiting aromatase, the enzyme responsible for the conversion of androgens to estrogens2 and also by promoting apoptosis of breast cancer cells.3 Nevertheless, despite its therapeutic success, this AI, after prolonged treatment, can induce acquired resistance, which causes tumor relapse. Therefore, it is important to find new strategies to overcome resistance in order to improve breast cancer treatment.

Methods: The presence of CB1 and CB2 in LTEDaro cells was confirmed by Western blot analysis and the effects of the combination of cannabinoids with exemestane were evaluated by MTT and LDH assays. Cell morphology was analyzed by Giemsa and Hoechst staining.

Results: Our results demonstrate that all the cannabinoids induce a decrease in viability of exemestane-resistant cells, in a dose- and time-dependent manner, without LDH release. These results indicate that the studied cannabinoids, mainly THC and AEA, revert the resistance to exemestane, probably by inducing apoptosis, as observed in Giemsa/Hoechst stain by the presence of typical morphological features of apoptosis.

Conclusion: This study highlights the efficacy of using cannabinoids as a potential adjuvant treatment to revert resistance to AIs.

Acknowledgements: Amaral C. grant (SFRH/BPD/98304/2013), Augusto T. (BD/128333/2017) and (UID/MULTI/04378/2013–POCI/01/0145/FERDER/007728); Prof. Shiuan Chen (Beckman Research Institute, USA) for LTEDaro cells.

References
[1]
S. Chen.
An “omics” approach to determine the mechanisms of acquired aromatase inhibitor resistance.
OMICS, 15 (2011), pp. 347-352
[2]
A.F. Sobral, C. Amaral, G. Correia-da-Silva, N. Teixeira.
Unravelling exemestane: from biology to clinical prospects.
J Steroid Biochem Mol Biol, 163 (2016), pp. 1-11
[3]
C. Amaral, M. Borges, S. Melo, E.T. da Silva, G. Correia-da-Silva, N. Teixeira.
Apoptosis and autophagy in breast cancer cells following exemestane treatment.
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos